Scarica l'app Stockscreener
0.7186
3.48%
-0.0259
Dopo l'orario di chiusura:
.73
0.0114
+1.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUMA Giù?
Forum
Previsione
Humacyte Inc Borsa (HUMA) Ultime notizie
Humacyte Inc (HUMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Humacyte Says US FDA Accepted IND for Human Trial of Coronary Tissue Engineered Vessel in Surgery - Moomoo
Humacyte Inc (HUMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
FDA accepts Humacyte IND for coronary bypass graft study - Investing.com
Humacyte Announces FDA Acceptance of IND for First-In-Human Clinical Study of CTEV for Coronary Artery Bypass Grafting - The Manila Times
Humacyte Plans First Human Study of Bioengineered Vessel in Heart Bypass - Stock Titan
Humacyte Inc (HUMA) Cash Flow - TradingKey
Humacyte Inc (HUMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Humacyte Inc (HUMA) Institutional Confidence - TradingKey
HUMA|Humacyte Inc|Price:0.674|Chg%:+0.050 - TradingKey
Humacyte Inc (HUMA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Humacyte Market Sentiment - Benzinga España
HUMA|Humacyte Inc|Price:0.625|Chg%:-0.014 - TradingKey
Price to sales forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 221% Upside in Biotech Innovation - DirectorsTalk Interviews
Humacyte Inc (HUMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Humacyte, Inc. (HUMA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Lobbying Update: $50,000 of HUMACYTE lobbying was just disclosed - Quiver Quantitative
Humacyte, Inc. (HUMA) suffers a larger drop than the general market: Key insights - MSN
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Enterprise value to EBIT forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Investor Notice: Robbins LLP Informs Stockholders of the Class A - GuruFocus
Humacyte, Inc. (HUMA) beats stock market upswing: What investors need to know - MSN
Humacyte appoints two nephrologists as commercial advisors By Investing.com - Investing.com South Africa
Humacyte appoints two nephrologists as commercial advisors - Investing.com
Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access - The Manila Times
Two Kidney Specialists Join Humacyte Ahead of Planned Dialysis Access - Stock Titan
Form 13D/A HUMACYTE For: 13 July By Investing.com - Investing.com Nigeria
Fresenius to sell 5M Humacyte (HUMA) shares under Rule 10b5-1 plan - Stock Titan
Humacyte Inc (HUMA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Humacyte, Inc. (HUMA) stock sinks as market gains: Here's why - MSN
Humacyte, Inc. (HUMA) Stock Declines While Market Improves: Some Information for Investors - MSN
HUMAHumacyte Inc Options - Finviz
HUMA Should I Buy - Intellectia AI
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securitie - GuruFocus
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Enterprise value to revenue forward of Humacyte, Inc. – NASDAQ:HUMAW - TradingView
Humacyte, Inc. Warrant 2021-27.08.26 on Humacyte Financial Disclosures & SEC Filings - TradingView
Humacyte, Inc. (HUMA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Humacyte Announces $50 Million Public Offering of Common Stock - Global Legal Chronicle
HUMA stock plunges after-hours on proposed share offering even as dialysis data impresses - MSN
Here's Why Humacyte, Inc. (HUMA) Fell More Than Broader Market - MSN
Enterprise value to revenue forward of Humacyte, Inc. – NASDAQ:HUMA - TradingView
Price to earnings forward of Humacyte, Inc. – NASDAQ:HUMA - TradingView
Humacyte (HUMA) Stock Fair Value Falls As Split Analyst Views Follow V012 Data - Yahoo Finance
Price to earnings forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Humacyte, Inc. (HUMA) latest stock news and headlines - Yahoo Finance Singapore
Price to book forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Price to sales forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Enterprise value to revenue forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Humacyte, Inc. Actuals & Estimates (NASDAQ:HUMA) - TradingView
Enterprise value to EBITDA forward of Humacyte, Inc. – BOATS:HUMA - TradingView
Enterprise value to EBIT forward of Humacyte, Inc. – BOATS:HUMA - TradingView
HUMA Forecast — Price Target — Prediction for 2027 - TradingView
BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Cuts Target Price to $2 - Moomoo
Form 13G Humacyte For: 22 June By Investing.com - Investing.com South Africa
Davidson Kempner reports 4.74% stake in Humacyte (NASDAQ: HUMA) - Stock Titan
0.35%
1.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):